RANGE IMPACT, INC. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market Information Our common stock has been quoted through various over-the-counter quotation systems at various times since 2009. Our common stock currently trades on the OTC Markets under the symbol “RNGE.” The following table sets forth the range of reported high and low closing bid quotations for our common stock for the fiscal quarters indicated as reported by OTC Markets Group. Common stock price reflects inter-dealer quotations, does not include retail markups, markdowns or commissions and does not necessarily represent actual transactions. High Low Fiscal Year Ended December 31, 2022 First Quarter ended March 31, 2022 $ 0.37 $ 0.13 Second Quarter ended June 30, 2022 0.25 0.12 Third Quarter ended September 30, 2022 0.20 0.13 Fourth Quarter ended December 31, 2022 0.21 0.13 Fiscal Year Ended December 31, 2023 First Quarter ended March 31, 2023 $ 0.20 $ 0.15 Second Quarter ended June 30, 2023 0.20 0.15 Third Quarter ended September 30, 2023 0.20 0.10 Fourth Quarter ended December 31, 2023 0.37 0.12 Transfer Agent The transfer agent and registrar for our common stock is Securities Transfer Corporation, 2901 North Dallas Parkway, Suite 380, Plano, Texas 75093. Holders of Common Stock As of March 28 , 2024, there were 70 holders of record of our common stock. Dividends We have never declared or paid any cash dividends or distributions on our common stock. We currently intend to retain our future earnings, if any, to support operations and to finance expansion, and we do not anticipate paying any cash dividends on our common stock in the foreseeable future. Equity Compensation Plan Information During the year ended December 31, 2023, we issued options to purchase 2,050,000 shares of the Company’s common stock under the Range Impact, Inc. 2021 Stock Incentive Plan. Except as listed in the table below, as of December 31, 2023, we do not have any equity-based plans, including individual compensation arrangements, which have not been approved by our stockholders. 36 The following table provides information as of December 31, 2023 with respect to our equity compensation plans: Equity Compensation Plan Information Plan Category Number of securities to be issued upon exercise of outstanding options, warrants and rights Weighted- average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (a) (b) (c) Equity compensation plans approved by security holders 11,392,544 $ 0.47 4,150,000 Total 11,392,544 $ 0.47 4,150,000 Item 6. Selected Financial Data Not applicable.